• Procalcitonin in newborns. Ambiguity of the evaluation
To content

Procalcitonin in newborns. Ambiguity of the evaluation

SOVREMENNAYA PEDIATRIYA.2018.5(93):37-41; doi 10.15574/SP.2018.93.37

Tantsiura L. D.
Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine

Procalcitonin is a marker of infection contamination, which is commonly used for early diagnostics of bacterial sepsis and a corresponding response to antibacterial therapy. Procalcitonin is synthesized in the normal condition in small amounts by the thyroid gland and is a peptide precursor of the hormone calcitonin. In a response to the contamination, lots of tissues and cells of the body start to produce procalcitonin, which enters the systemic circulation in large quantities. When interpreting the values of procalcitonin in blood plasma in newborns, their perinatal kinetics must be considered. In normal physiological conditions, the procalcitonin plasma concentration during the first days of life is increased. A contributor to the transient increase in the procalcitonin plasma level in healthy newborns is the rapid colonization of skin surface and mucous membranes by various microorganisms immediately after birth. The dynamics of the procalcitonin reduction in the preterm newborns is much slower than in the full-term ones, which is due to the metabolic features and immaturity of the excretory mechanisms. The cause of procalcitonin increase in neonates may be non'infectious factors. Consequently, threshold values of procalcitonin for the diagnosis of sepsis in the first few days of life differ from the standard reference ranges. Interpretation of the procalcitonin level in neonates should not be isolated and take into account clinical data.
Key words: procalcitonin, reference ranges, neonates, sepsis


1. Altunhan H, Annagur A, Ors R et al. (2011). Procalcitonin measurement at 24 hours of age may be helpful in the prompt diagnosis of early onset neonatal sepsis. Int J Infect Dis. 15:854–858. https://doi.org/10.1016/j.ijid.2011.09.007; PMid:22019570

2. Assuma M, Signore F, Pacifico L et al. (2000). Serum procalcitonin concentrations in term delivering mothers and their healthy offsprings: A longitudinal study. Clin Chem. 46:1583—1587.

3. Becker KL, Snider R, Nylen ES. (2008). Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med. 36(03):941—952. https://doi.org/10.1097/CCM.0B013E318165BABB; PMid:18431284

4. Benitz WE. (2010). Adjunct laboratory tests in the diagnosis of early-on-set neonatal sepsis. Clin. Perinatol. 37: 421—438. https://doi.org/10.1016/j.clp.2009.12.001; PMid:20569816

5. Chiesa C, Natale F, Pascone R et al. (2011). C reactive protein and procalcitonin: reference intervals for preterm and term newborns during the early neonatal period. Clin Chim Acta. 412:1053—1059. https://doi.org/10.1016/j.cca.2011.02.020; PMid:21338596

6. Chiesa C, Panero A, Rossi N et al. (1998). Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin Infect Dis. 26(03):664—672. https://doi.org/10.1086/514576; PMid:9524841

7. Chiesa C, Pellegrini G, Panero A et al. (2003). C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: influence of illness severity, risk status, antenatal and perinatal complications, and infection. Clin Chem. 49(01):60—68. https://doi.org/10.1373/49.1.60; PMid:12507961

8. Davies J. (2015). Procalcitonin. J Clin Pathol. 68: 675—679. https://doi.org/10.1136/jclinpath-2014-202807; PMid:26124314

9. Fukuzumi N, Osawa K, Sato I et al. (2016). Age-specific percentile-based reference curve of serum procalcitonin concentrations in Japanese preterm infants. Scientific Reports. 6:23871. https://doi.org/10.1038/srep23871; PMid:27033746 PMCid:PMC4817150

10. Groselj-Grenc M, Ihan A, Pavcnik-Arnol M et al. (2009). Neutrophil and monocyte CD64 indexes, lipopolysaccharide-binding protein, procalcitonin and C-reactive protein in sepsis of critically ill neonates and children. Intensive Care Med. 35(11): 1950—1958. https://doi.org/10.1007/s00134-009-1637-7; PMid:19756501

11. Hans-Gerhard Schneider, Que Thanh Lam. (2007). Procalcitonin for the clinical laboratory: a review. Pathology. 39(4): 383—390. https://doi.org/10.1080/00313020701444564; PMid:17676478

12. Jokic M, Guillois B, Cauquelin B et al. (2000). Fetal distress increases interleukin-6 and interleukin-8 and decreases tumour necrosis factor-α cord blood levels in noninfected full-term neonates. Br J Ob Gyn. 107:420—425. https://doi.org/10.1111/j.1471-0528.2000.tb13241.x

13. Lam HS, Ng PC. (2008). Biochemical markers of neonatal sepsis. Pathology. 40:141—148. https://doi.org/10.1080/00313020701813735; PMid:18203036

14. Lapillonne A, Basson E, Monneret G et al. (1998). Lack of specificity of procalcitonin for sepsis diagnosis in premature infants. Lancet. 351:1211—1212. https://doi.org/10.1016/S0140-6736(05)79165-0

15. Levy O. (2007). Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol. 7:379—390. https://doi.org/10.1038/nri2075; PMid:17457344

16. Llorente E, Prieto B, Cardo L et al. (2007). Umbilical cord blood serum procalcitonin by time-resolved amplified cryptate emission (TRACE) technology: Reference values of a potential marker of vertically transmitted neonatal sepsis. Clin Chem Lab Med. 45: 1531—1535. https://doi.org/10.1515/CCLM.2007.304; PMid:17892436

17. Lopez-Sastre L, Solis DP, Serradilla VR et al. (2007). Evaluation of procalcitonin for the diagnosis of neonatal sepsis of vertical transmission. BMC Pediatr. 7:9. Published online 2007 Feb 26. https://doi.org/10.1186/1471-2431-7-9; PMid:17324267 PMCid:PMC1828911

18. Marchini G, Berggren V, Djilali-Merzoug R, Hansson LO. (2000). The birth process initiates an acute phase reaction in the fetus-newborn infant. Acta Pediatr. 89:1082–1086. https://doi.org/10.1111/j.1651-2227.2000.tb03355.x; PMid:11071089

19. Markic J, Saragа M, Dahlem P. (2017). Sepsis Biomarkers in Neonates and Children: C-Reactive Protein and Procalcitonin. J Child Sci. 1:89-95.

20. Monneret G, Labaune JM, Isaac C et al. (1998). Increased serum procalcitonin levels are not specific to sepsis in neonates. Letter. Clin Infect Dis. 27:1559–1560. https://doi.org/10.1086/517758; PMid:9868696

21. Müller B, White JC, Nylen ES, Snider RH, Becker KL, Habener JF. (2001). Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab. 86(01):396–404. https://doi.org/10.1210/jc.86.1.396; https://doi.org/10.1210/jcem.86.1.7089

22. Ochi F, Higaki T, Ohta M et al. (2014). Procalcitonin as a marker of respiratory disorder in neonates. Pediatrics International. 57(2):263–268. https://doi.org/10.1111/ped.12505; PMid:25223367

23. Pontrelly G, De Crescenzo F, Buzzetti R et al. (2017). Accuracy of serum procalcitonin for the diagnosis of sepsis in neonates and children with systemic inflammatory syndrome: a meta-analysis. (2017) BMC Infect Dis. 17(1):302. Published online 2017 Apr 24. https://doi.org/10.1186/s12879-017-2396-7; PMid:28438138 PMCid:PMC5404674

24. Resch B, Gusenleitner W, Muller WD. (2003). Procalcitonin and interleukin-6 in the diagnosis of early onset sepsis of the neonate. Acta Paediatr. 92(02):243–245. https://doi.org/10.1111/j.1651-2227.2003.tb00534.x; PMid:12710654

25. Sachse C, Dressler F, Henkel E. (1998). Increased serum procalcitonin in newborn infants without infection. Clin Chem. 44:1343–1344. PMid:9625064

26. Schuetz P, Chiappa V, Briel M et al. (2011). Procalcitonin algorithms for antibiotic therapy decisions. Arch Intern Med. 171:1322–1331. https://doi.org/10.1001/archinternmed.2011.318; PMid:21824946

27. Stocker M, Hop WC, van Rossum AM. (2010). Neonatal Procalcitonin Intervention Study (NeoPIns): effect of peocalcitonin–guided decision making on duration of antibiotic therapy in suspected neonatal early onset sepsis: s multicenter randomized superiority and non–inferiority intervention study. BMC Pediatr. 10:89–96. https://doi.org/10.1186/1471-2431-10-89; PMid:21143869 PMCid:PMC3016366

28. Turner D, Hammerman C, Rudensky B et al. (2006). Procalcitonin in preterm infants during the first few days of life: introducing an age related nomogram. Arch Dis Child Fetal Neonatal Ed. 91: 283–286. https://doi.org/10.1136/adc.2005.085449; PMid:16547079 PMCid:PMC2672732

29. Turner D, Hammerman C, Rudensky B et al. (2006). The role of procalcitonin as a predictor of nosocomial sepsis in preterm infants. Acta Paediatr. 95(12):1571–1576. https://doi.org/10.1080/08035250600767811; PMid:17129964

30. Vijayan AL, Vanimaya, Ravindran S et al. (2017). Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy. J Intensive Care. 5:51. https://doi.org/10.1186/s40560-017-0246-8; PMid:28794881 PMCid:PMC5543591

Article received: Feb 21, 2018. Accepted for publication: Sep 14, 2018.